This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (13)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

C. F. Essig, MD; B. Edson Jones, PhD; R. C. Lam, MD

Arch Neurol. 1969;20(5):554-558.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

DELIRIUM TREMENS or convulsions are serious abstinence manifestations of physical dependence on alcohol (ethanol).^1-3 This withdrawal syndrome can be associated with a fatal outcome, and its treatment is controversial, as indicated by the variety of results obtained with both old and new drugs that are being used in its management.^2,4-8 Although the pharmacotherapy of this condition is most validly determined in man, clinical trials can be hazardous. A clinical comparison of paraldehyde and a phenothiazine in treating alcoholic delirium tremens was associated with mortality rates of 4.5% and 35%, respectively.⁸

Since clinical trials of drugs proposed for the treatment of delirium tremens involve hazards, it would be desirable to have an animal model to evaluate such drugs so that ineffective agents might be eliminated or tried only with extreme caution in the clinic. Recently it has been shown that dogs will develop physical dependence on alcohol . . . [Full Text PDF of this Article]

Author Affiliations
Lexington, Ky

From the National Institute of Mental Health, Addiction Research Center and Clinical Research Center, Lexington, Ky.

Footnotes
Submitted for publication Dec 13, 1968; accepted Dec 24.

Reprint requests to Box 2000, Lexington, Ky 40507 (Dr. Essig).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?